187 related articles for article (PubMed ID: 36139650)
1. Concomitant Inhibition of FASN and SREBP Provides a Promising Therapy for CTCL.
Chi C; Harth L; Galera MR; Torrealba MP; Vadivel CK; Geisler C; Bonefeld CM; Nielsen PR; Bzorek M; Becker JC; Gjerdrum LMR; Ødum N; Woetmann A
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139650
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
Huang LH; Chung HY; Su HM
BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
[TBL] [Abstract][Full Text] [Related]
3. mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy.
Knaneh J; Hodak E; Fedida-Metula S; Edri A; Eren R; Yoffe Y; Amitay-Laish I; Prag Naveh H; Lubin I; Porgador A; Moyal L
Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686697
[No Abstract] [Full Text] [Related]
4. High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade.
Kiessling MK; Oberholzer PA; Mondal C; Karpova MB; Zipser MC; Lin WM; Girardi M; Macconaill LE; Kehoe SM; Hatton C; French LE; Garraway LA; Polier G; Süss D; Klemke CD; Krammer PH; Gülow K; Dummer R
Blood; 2011 Feb; 117(8):2433-40. PubMed ID: 21209378
[TBL] [Abstract][Full Text] [Related]
5. Novel therapeutic approaches for cutaneous T cell lymphomas.
Pavlidis A; Piperi C; Papadavid E
Expert Rev Clin Immunol; 2021 Jun; 17(6):629-641. PubMed ID: 33890833
[No Abstract] [Full Text] [Related]
6. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD.
Du X; Cai C; Yao J; Zhou Y; Yu H; Shen W
Biochem Biophys Res Commun; 2017 Jan; 483(1):409-417. PubMed ID: 28027934
[TBL] [Abstract][Full Text] [Related]
7. Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas.
Dusílková N; Bašová P; Polívka J; Kodet O; Kulvait V; Pešta M; Trněný M; Stopka T
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036928
[TBL] [Abstract][Full Text] [Related]
8. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
McCaffrey S; Black RA; Nagao M; Sepassi M; Sharma G; Thornton S; Kim YH; Braverman J
J Med Internet Res; 2019 Jan; 21(1):e11302. PubMed ID: 30617041
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
10. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
11. Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma.
Lin M; Kowolik CM; Xie J; Yadav S; Overman LE; Horne DA
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282785
[TBL] [Abstract][Full Text] [Related]
12. An overview of cutaneous T cell lymphomas.
Bagherani N; Smoller BR
F1000Res; 2016; 5():. PubMed ID: 27540476
[TBL] [Abstract][Full Text] [Related]
13. Polyunsaturated fatty acid suppression of fatty acid synthase (FASN): evidence for dietary modulation of NF-Y binding to the Fasn promoter by SREBP-1c.
Teran-Garcia M; Adamson AW; Yu G; Rufo C; Suchankova G; Dreesen TD; Tekle M; Clarke SD; Gettys TW
Biochem J; 2007 Mar; 402(3):591-600. PubMed ID: 17313375
[TBL] [Abstract][Full Text] [Related]
14. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
[TBL] [Abstract][Full Text] [Related]
15. Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor.
Hansmannel F; Mordier S; Iynedjian PB
Biochem J; 2006 Oct; 399(2):275-83. PubMed ID: 16834571
[TBL] [Abstract][Full Text] [Related]
16. The Ectopic Expression of Meiosis Regulatory Genes in Cutaneous T-Cell Lymphomas (CTCL).
Gantchev J; Martínez Villarreal A; Xie P; Lefrançois P; Gunn S; Netchiporouk E; Sasseville D; Litvinov IV
Front Oncol; 2019; 9():429. PubMed ID: 31214493
[TBL] [Abstract][Full Text] [Related]
17. Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma.
Ezzeddini R; Taghikhani M; Somi MH; Samadi N; Rasaee MJ
Life Sci; 2019 May; 224():169-176. PubMed ID: 30914315
[TBL] [Abstract][Full Text] [Related]
18. Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.
Gill RPK; Gantchev J; Martínez Villarreal A; Ramchatesingh B; Netchiporouk E; Akilov OE; Ødum N; Gniadecki R; Koralov SB; Litvinov IV
Cells; 2022 Feb; 11(4):. PubMed ID: 35203244
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Breast Cancer Cell FASN Expression by Obesity-Related Systemic Factors.
McClellan B; Pham T; Harlow B; Lee G; Quach D; Jolly C; Brenner A; deGraffenried L
Breast Cancer (Auckl); 2022; 16():11782234221111374. PubMed ID: 36035625
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.
Tao T; Su Q; Xu S; Deng J; Zhou S; Zhuang Y; Huang Y; He C; He S; Peng M; Hocher B; Yang X
J Cell Physiol; 2019 Mar; 234(3):3088-3104. PubMed ID: 30221356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]